About The Study: In this phase 2 prospective validating paired cohort study, fluorine-18 PSMA-1007 PET/computed tomography was superior to magnetic resonance imaging (MRI) for the locoregional staging of prostate cancer. These findings support PSMA PET in the preoperative workflow of intermediate-risk and high-risk tumors.
About The Study: In this phase 2 prospective validating paired cohort study, fluorine-18 PSMA-1007 PET/computed tomography was superior to magnetic resonance imaging (MRI) for the locoregional staging of prostate cancer. These findings support PSMA PET in the preoperative workflow of intermediate-risk and high-risk tumors.
Corresponding Author: To contact the corresponding author, Adam Kinnaird, M.D., Ph.D., email ask@ualberta.ca.
To access the embargoed study: Visit our For The Media website at this link
(doi:10.1001/jamaoncol.2024.3196)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Media advisory: This study is being presented at the Canadian Urological Association Annual Meeting.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time
Journal
JAMA Oncology
